Stockreport

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023

ESSA Pharma Inc.  (EPIX) 
Last essa pharma inc. earnings: 2/13 05:48 pm Check Earnings Report
US:NASDAQ Investor Relations: essapharma.com/investors
PDF Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in Phase 1 dose escalation in patients with mCRPC, in [Read more]